Here, we demonstrate detection by mass spectrometry of an intact protein-drug complex directly from liver tissue from rats that had been orally dosed with the drug. The protein-drug complex comprised fatty acid binding protein 1, FABP1, non-covalently bound to the small molecule therapeutic bezafibrate. Moreover, we demonstrate spatial mapping of the [FABP1+bezafibrate] complex across a thin section of liver by targeted mass spectrometry imaging. This work is the first demonstration of in situ mass spectrometry analysis of a non-covalent protein-drug complex formed in vivo and has implications for early stage drug discovery by providing a route to target-drug characterization directly from the physiological environment.</p
AbstractNative liquid extraction surface analysis (LESA) mass spectrometry enables the direct sampli...
Lipids and their secondary metabolites function as energy storage molecules, structural components i...
Mass spectrometry (MS) has recently emerged as an efficient analytical tool in early drug discovery,...
Here, we demonstrate detection by mass spectrometry of an intact protein-drug complex directly from ...
Label-free spatial mapping of the noncovalent interactions of proteins in their tissue environment h...
Native mass spectrometry seeks to probe noncovalent protein interactions in terms of protein quatern...
Mass spectrometry data to accompany "Mass Spectrometry Detection and Imaging of a Non-Covalent Prote...
Native mass spectrometry seeks to probe noncovalent protein interactions in terms of protein quatern...
Mass spectrometry imaging (MSI) provides information on the spatial distribution of molecules within...
While proteomics, mass spectrometry and their combination have seen great advancements since their i...
Analytical methods are pursued to measure the identity and location of biomolecules down to the subc...
Most targets for drug discovery are proteins. Drug discovery includes target identification and vali...
Untargeted label-free interrogation of proteins in their functional form directly from their physiol...
AbstractNative liquid extraction surface analysis (LESA) mass spectrometry enables the direct sampli...
Lipids and their secondary metabolites function as energy storage molecules, structural components i...
Mass spectrometry (MS) has recently emerged as an efficient analytical tool in early drug discovery,...
Here, we demonstrate detection by mass spectrometry of an intact protein-drug complex directly from ...
Label-free spatial mapping of the noncovalent interactions of proteins in their tissue environment h...
Native mass spectrometry seeks to probe noncovalent protein interactions in terms of protein quatern...
Mass spectrometry data to accompany "Mass Spectrometry Detection and Imaging of a Non-Covalent Prote...
Native mass spectrometry seeks to probe noncovalent protein interactions in terms of protein quatern...
Mass spectrometry imaging (MSI) provides information on the spatial distribution of molecules within...
While proteomics, mass spectrometry and their combination have seen great advancements since their i...
Analytical methods are pursued to measure the identity and location of biomolecules down to the subc...
Most targets for drug discovery are proteins. Drug discovery includes target identification and vali...
Untargeted label-free interrogation of proteins in their functional form directly from their physiol...
AbstractNative liquid extraction surface analysis (LESA) mass spectrometry enables the direct sampli...
Lipids and their secondary metabolites function as energy storage molecules, structural components i...
Mass spectrometry (MS) has recently emerged as an efficient analytical tool in early drug discovery,...